A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This research is being done because there is no treatment that will cure this type of cancer.
Although some types of chemotherapy can cause this cancer to shrink for a time, better
options are needed.